Science

Scientists warn of political gatekeeping in federal rule

Leaders across major US science and health organizations are sounding the alarm over a proposed federal rule they say would shift funding decisions away from peer review and toward political priorities—creating uncertainty for long-term research and potentiall

By the time the debate reaches the national science community, it’s no longer abstract. It’s about whether the work that takes years—often decades—can survive the moment-to-moment swings of politics.

Shane Jacobson, CEO of the American Cancer Society, put that concern in stark terms. In a statement. he warned that “codifying shifting policy preferences into formal federal regulations risks triggering repeated cycles of overhaul with each change in administration.” He said the result would be “a chronically unpredictable environment. ” one that would make it “extremely difficult for institutions and investigators to plan and sustain the multi-year. long-term research essential to clinical trials and breakthrough discoveries that patients urgently need.”.

Nancy Brown of the American Heart Association echoed that fear, tying it directly to scientific independence. She said. “Policies that undermine independence or shift decisions away from established scientific and public health expertise risk weakening the innovation and collaboration needed to meet current and future health challenges.”.

The pushback is not limited to biomedicine. The American Geophysical Union called the change “a rule that would rewrite the terms of US science.” It accused the government of “using the language of scientific rigor as a screen for political gatekeeping.”

That charge cuts to a specific mechanism described in the union’s statement. It warned that political officials would have authority to reject proposals that passed expert evaluation if they determine the work does not advance “the President’s policy priorities” or is inconsistent with “the national interest. ” and that such determinations could change “at any moment.” The American Geophysical Union argued that the scientific community has spent “generations building peer review precisely because decisions about which science to fund should rest on scientific merit. not political alignment.” It said the proposal would “undo that.”.

The American Physical Society delivered its critique with equal force. listing consequences that would hit day-to-day research life: “These proposals would let political preference override expert peer review. restrict travel. limit collaboration. impede the sharing of results. and affect programs that train the next generation of scientists.” It then framed the long-term cost as bigger than any single administration. “The proposed federal rule would establish regulations that would have politics shadow every research dollar. making it far harder to undo. no matter who holds office next.”.

In a follow-up, the American Physical Society added that “the proposal crosses the line, threatening all science, under any administration, now and into the future.”

Taken together, the statements from health groups, geoscientists, and physicists describe a single shift they say could reshape what peer review is meant to protect: time, independence, and the ability to plan beyond an election cycle.

American Cancer Society Nancy Brown American Heart Association American Geophysical Union American Physical Society peer review federal rule research funding clinical trials political gatekeeping scientific independence

4 Comments

  1. I didn’t read all of it but peer review being replaced with political priorities?? That seems… not ideal. We already have enough uncertainty in healthcare.

  2. Wait, so the President can just overrule scientists even after the experts approve it? That’s kinda wild, but also I feel like this is already happening. Like they say it’s “national interest” but it just means whatever party’s in charge that year. Unless I’m misunderstanding.

  3. This sounds like those articles where everyone’s mad about “gatekeeping” but nobody actually explains what the rule does day to day. Like does it affect grants or clinical trials or both? I swear every administration changes funding priorities anyway, so now they’re just putting it in writing? Meanwhile, people are acting like science is supposed to be totally detached from politics… but it never is, right?

Leave a Reply

Your email address will not be published. Required fields are marked *

Are you human? Please solve:Captcha


Secret Link